Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Share Price
NASDAQ: FBIOP | Small Cap$15.91
+$15.91 (--%) Last updated on 29 Oct, 2026 | 20:28 ISTFortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Stock Performance
Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Share Price Chart
$15.91$15.93
L
H
Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Quarterly Profit & Loss
All figures in USD
Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Annual Profit & Loss
All figures in USD
About Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $16.27 | $15.91 | -2.81% |
Sep 2026 | $18.56 | $16.37 | -9.11% |
Aug 2026 | $18.93 | $18.01 | -4.46% |
Jul 2026 | $19.52 | $18.85 | -6.27% |
Jun 2026 | $20.50 | $20.11 | +3.29% |
May 2026 | $14.05 | $19.47 | +48.74% |
Apr 2026 | $13.48 | $13.09 | -1.80% |
Mar 2026 | $14.01 | $13.33 | -8.07% |
Feb 2026 | $12.07 | $14.50 | +17.98% |
Jan 2026 | $9.73 | $12.29 | +33.01% |
Dec 2025 | $6.70 | $9.24 | +37.09% |
Nov 2025 | $6.81 | $6.74 | -3.02% |